| Literature DB >> 26950238 |
Marc Beyer1,2, Zeinab Abdullah3, Jens M Chemnitz4, Daniela Maisel4, Jil Sander1, Clara Lehmann4,5, Yasser Thabet1,6, Prashant V Shinde6, Lisa Schmidleithner1, Maren Köhne1, Jonel Trebicka7, Robert Schierwagen7, Andrea Hofmann1,8, Alexey Popov1, Karl S Lang9, Annette Oxenius10, Thorsten Buch11, Christian Kurts3, Mathias Heikenwalder12,13, Gerd Fätkenheuer4,5, Philipp A Lang6,14, Pia Hartmann4,5,15, Percy A Knolle3,16, Joachim L Schultze1,2.
Abstract
Persistent viral infections are characterized by the simultaneous presence of chronic inflammation and T cell dysfunction. In prototypic models of chronicity--infection with human immunodeficiency virus (HIV) or lymphocytic choriomeningitis virus (LCMV)--we used transcriptome-based modeling to reveal that CD4(+) T cells were co-exposed not only to multiple inhibitory signals but also to tumor-necrosis factor (TNF). Blockade of TNF during chronic infection with LCMV abrogated the inhibitory gene-expression signature in CD4(+) T cells, including reduced expression of the inhibitory receptor PD-1, and reconstituted virus-specific immunity, which led to control of infection. Preventing signaling via the TNF receptor selectively in T cells sufficed to induce these effects. Targeted immunological interventions to disrupt the TNF-mediated link between chronic inflammation and T cell dysfunction might therefore lead to therapies to overcome persistent viral infection.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26950238 DOI: 10.1038/ni.3399
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606